Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

被引：0
|
作者：
Allahyari, A. [1 ]
Jernberg, T. [1 ]
Lautsch, D. [2 ]
Lundman, P. [1 ]
Hagstrom, E. [3 ]
Schubert, J. [3 ]
Boggs, R. [2 ]
Salomonsson, S. [4 ]
Ueda, P. [5 ]
机构：
[1] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden
[4] Merck Sharp & Dohme Ltd, Stockholm, Sweden
[5] Karolinska Inst, Div Clin Epidemiol, Dept Med, Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P828
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [41] Means and ends of statins and low-density lipoprotein cholesterol lowering
    LaRosa, John C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (05) : 419 - 420
  • [42] Low-density lipoprotein cholesterol lowering treatment: the current approach
    Crismaru, Irina
    Pantea Stoian, Anca
    Bratu, Ovidiu Gabriel
    Gaman, Mihnea-Alexandru
    Stanescu, Ana Maria Alexandra
    Bacalbasa, Nicolae
    Diaconu, Camelia Cristina
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [43] Lowering low-density lipoprotein cholesterol: from mechanisms to therapies
    Luo, Jie
    Wang, Jin-Kai
    Song, Bao-Liang
    LIFE METABOLISM, 2022, 1 (01): : 25 - 38
  • [44] ATTAINMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL TARGETS IN PATIENTS TREATED WITH COMBINATION THERAPY IN AUSTRALIA: A RETROSPECTIVE COHORT STUDY OF A PRIMARY CARE DATABASE
    Marquina, C.
    Tallic, S.
    Zomer, E.
    Abushanab, D.
    Ofori-Asenso, R.
    Lybrand, S.
    Liew, D.
    Ademi, Z.
    VALUE IN HEALTH, 2022, 25 (01) : S249 - S249
  • [45] Low-density lipoprotein cholesterol lowering treatment: the current approach
    Irina Crismaru
    Anca Pantea Stoian
    Ovidiu Gabriel Bratu
    Mihnea-Alexandru Gaman
    Ana Maria Alexandra Stanescu
    Nicolae Bacalbasa
    Camelia Cristina Diaconu
    Lipids in Health and Disease, 19
  • [46] Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol
    Samuel, Essie
    Watford, Maya
    Egolum, Ugochukwu O.
    Ombengi, David N.
    Ling, Hua
    Cates, Drew W.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (03) : 317 - 324
  • [47] Influence of Low-Density Lipoprotein Cholesterol Levels on NSAID-Associated Cardiovascular Risks After Myocardial Infarction: A Population-Based Cohort Study
    Basem, Mohab
    Bonnesen, Kasper
    Pedersen, Lars
    Sorensen, Henrik Toft
    Schmidt, Morten
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 281 - 291
  • [48] Low-Density Lipoprotein Cholesterol-Lowering Therapy for Atherosclerotic Cardiovascular Disease in the Future
    Abe, Shichiro
    Nishino, Setus
    Kanaya, Tomoaki
    Sakuma, Masashi
    Toyoda, Shigeru
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 215
  • [49] A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
    Stampfer, MJ
    Krauss, RM
    Ma, J
    Blanche, PJ
    Holl, LG
    Sacks, FM
    Hennekens, CH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11): : 882 - 888
  • [50] Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction
    Iwata, Atsushi
    Miura, Shin-ichiro
    Shirai, Kazuyuki
    Kawamura, Akira
    Tomita, Sayo
    Matsuo, Yoshino
    Zhang, Bo
    Nishikawa, Hiroaki
    Kumagai, Koichiro
    Matsuo, Kunihiro
    Saku, Keijiro
    INTERNAL MEDICINE, 2006, 45 (15) : 885 - 890
12345